LAKE FOREST, CA – September 8, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, announced today the appointment of Curt Kole to the new role of VP, Strategic Business Development. Cryoport’s new business development personnel will support the Company’s rapid development and integration of large-scale corporate clients. In addition to securing new business sectors and major accounts for Cryoport, this new function will be responsible for the management of many key partnerships for the Company.
Read More
Tags:
Frozen Shipping,
sales,
business development,
Curt Kole,
VP of Strategic Business Development,
Cold Chain Logistics,
Dry Shipper,
cold shipping,
Clinical Trials Logistics
LAKE FOREST, CA – September 2, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions, announced today that its Chief Financial Officer, Robert Stefanovich, is scheduled to present at the Aegis Healthcare & Technology Conference on Friday, September 12, 2014 at 1:30 pm PT, at The Encore at Wynn Las Vegas.
Read More
Tags:
Frozen Shipping,
Aegis Healthcare & Technology Conference,
Cold Chain Logistics,
Dry Shipper,
cold shipping,
Clinical Trials Logistics
LAKE FOREST, CA – August 12, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions, announced today the implementation of its sales force expansion program to accelerate the Company’s rapidly expanding customer base. In addition to our key market sectors, the expanded sales team will provide direct support to our global integrator partners, who uniquely employ Cryoport’s ‘powered by Cryoport™’ solutions into their respective strategies for the life sciences cold chain.
Read More
Tags:
Frozen Shipping,
sales,
business development,
Cold Chain Logistics,
Dry Shipper,
cold shipping,
Clinical Trials Logistics
LAKE FOREST, CA – July 31, 2014 — Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the three month period ended June 30, 2014.
Recent Operating Highlights
Read More
Tags:
Frozen Shipping,
Revenue,
first quarter fiscal 2015,
Cold Chain Logistics,
Dry Shipper,
cold shipping,
Clinical Trials Logistics
LAKE FOREST, CA – July 16, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions, partners with LifeConEx, a part of DHL Global Forwarding, to enhance and supplement DHL’s cold chain logistics offerings including DHL Express’ Medical Express to its life sciences and healthcare customers with Cryoport’s comprehensive cryogenic logistics solutions.
Read More
Tags:
Frozen Shipping,
DHL,
Cold Chain Logistics,
Dry Shipper,
cold shipping,
Clinical Trials Logistics
LAKE FOREST, CA – July 1, 2014 – Cryoport, Inc. (OTCBB: CYRX) (“the Company”) today announced the release of its investor relations app for iPhone, iPad and Android mobile devices now available for free at Apple’s App Store for the iPhone and iPad https://itunes.apple.com/us/app/cryoport-investor-relations/id878258991?ls=1&mt=8 and at Google Play https://play.google.com/store/apps/details?id=com.theirapp.cryoport for Android mobile devices.
Read More
Tags:
Frozen Shipping,
Investor relations app,
free,
Cold Chain Logistics,
Dry Shipper,
cold shipping,
Clinical Trials Logistics
LAKE FOREST, CA – June 23, 2014 – Cryoport, Inc. (OTCBB: CYRX) (“the Company”) today announced that it has been chosen by Immudex to support its global distribution of biological materials and samples for proficiency panels to and from Immudex’s production and research facilities and customers.
Read More
Tags:
Frozen Shipping,
Immudex,
Cold Chain Logistics,
Dry Shipper,
cold shipping,
Clinical Trials Logistics
LAKE FOREST, CA – June 16, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading, global provider of advanced cryogenic logistics solutions, today announced the appointment of Ramkumar Mandalam, Ph.D., to its Board of Directors. Additionally, he has been appointed to serve as a member of the Compensation and Nominating and Governance Committees. Following Dr. Mandalam’s appointment, Cryoport’s Board of Directors will have a total of five members, including four independent members.
Read More
Tags:
Frozen Shipping,
shipping solution,
Frozen,
board,
Ramkumar Mandalam,
Ph.D.,
Cold Chain Logistics,
Dry Shipper,
cold shipping,
Clinical Trials Logistics
LAKE FOREST, CA – June 12, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions, today announced that it will be showcasing its patented Cryoport Express® Shippers and its Cryoportal™ Logistics Management Platform, a revolutionary, purpose-built technology which manages and monitors the entire cold chain logistics process for biologic materials, at the BioLogistics Summit in San Diego, California, on June 16th-18th.
Read More
Tags:
Frozen Shipping,
BioLogistics,
Cold Chain Logistics,
Dry Shipper,
cold shipping,
Clinical Trials Logistics
LAKE FOREST, CA – May 29, 2014 — Cryoport, Inc. (OTCBB: CYRX) (“the Company”), the leading provider of advanced cryogenic logistics solutions, today announced that Cenetron Diagnostics has expanded the use of its customized cryogenic logistics solution powered by Cryoport’s CryoportalTM and Cryoport Express® Shippers.
Read More
Tags:
Frozen Shipping,
Cold Chain Logistics,
Dry Shipper,
cold shipping,
Clinical Trials Logistics,
Cenetron
